BackscPharmaceuticals Overview

scPharmaceuticals Cost of Revenue

Cost of Revenue analysis for SCPH.

Quarterly Cost of Revenue

$5.01M
↑ 113.05% YoY

As of Jun 30, 2025

Annual Cost of Revenue (TTM)

$15.76M
↑ 123.84% YoY

Trailing 12 months ending Jun 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin